Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Cherington Charles, Director. Insider active across 4 companies, notably Brooklyn ImmunoTherapeutics, Inc.. Aggregated, 16 filings have been published. Split: 14 buys · 1 sell. Total volume traded: €7.4m. History available since 16 June 2021. The latest transaction was disclosed on 10 February 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Cherington Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
200,000 shares@ US$15.7338100.0% of flowCommon StockSEC:0001140361-21-021772:0
16 of 16 declarations
About Cherington Charles
Cherington Charles is Administrateur of Comera Life Sciences Holdings, Inc., Ernexa Therapeutics Inc., and Eterna Therapeutics Inc., and Director at Brooklyn ImmunoTherapeutics, Inc. He has 16 filings in total, and in the recent filings sampled from 2021-06-21 to 2026-02-17, purchases amount to EUR 4801095 and sales to EUR 2623265, with Acquisition as the most frequent transaction nature.